Skip to main content
. 2022 Jul 12;24(7):e36490. doi: 10.2196/36490

Table 2.

Distribution of the 131 studies based on malignancy type.

Malignancy type Values, n (%)
Acute myeloid leukemia 42 (32.1)
Acute lymphoblastic leukemia 40 (30.5)
Chronic lymphocytic leukemia 13 (9.9)
Chronic myeloid leukemia 2 (1.5)
Lymphoma 17 (13.0)
Other 17 (13.0)